Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000125701 | SCV000169165 | benign | not specified | 2013-04-08 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Laboratory for Molecular Medicine, |
RCV000125701 | SCV000270959 | likely benign | not specified | 2015-08-06 | criteria provided, single submitter | clinical testing | c.5260-15C>T in intron 41 of TSC2: This variant is not expected to have clinical significance because a C>T change at this position does not diverge from the sp lice consensus sequence and is therefore unlikely to impact splicing. It has bee n identified in 0.2% (132/65448) of European chromosomes by the Exome Aggregatio n Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs45517416). |
Prevention |
RCV000125701 | SCV000305247 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000043242 | SCV000395679 | likely benign | Tuberous sclerosis syndrome | 2018-02-22 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Genome- |
RCV001797607 | SCV002039936 | benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001797607 | SCV002487038 | benign | Tuberous sclerosis 2 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001579334 | SCV002545721 | likely benign | not provided | 2022-11-01 | criteria provided, single submitter | clinical testing | TSC2: BS1 |
KCCC/NGS Laboratory, |
RCV001797607 | SCV004016112 | benign | Tuberous sclerosis 2 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001797607 | SCV004360944 | likely benign | Tuberous sclerosis 2 | 2022-11-06 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001579334 | SCV004563380 | benign | not provided | 2023-08-18 | criteria provided, single submitter | clinical testing | |
Tuberous sclerosis database |
RCV000043242 | SCV000067043 | not provided | Tuberous sclerosis syndrome | no assertion provided | curation | ||
Genome Diagnostics Laboratory, |
RCV001579334 | SCV001806837 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000125701 | SCV001969676 | benign | not specified | no assertion criteria provided | clinical testing |